Liberty Health Sciences Reports Fiscal Year 2021 Second Quarter Financial Results *Note: All references to dollar values refer to Canadian dollars unless otherwise stated. TORONTO, ON, Oct. 30, 2020...
Liberty Health Sciences Announces Record Revenue Increase in Fiscal Year 2020 Financial Results; 401% Growth Combined revenue for the year ended is $50 million * All references to dollar...
Liberty Health Sciences Signs Agreement As First State Partner To Bring The Award-Winning PAX Era To The Florida Market TORONTO, Sept. 10, 2018 /PRNewswire/ – Liberty Health Sciences Inc. (CSE: LHS)...
Aphria completes divestment of all U.S. cannabis assets with sale of remaining interest in Liberty Health Sciences Aphria clears balance sheet of U.S. cannabis investments and will reenter U.S....
